Knight Therapeutics Inc.
GUD.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 85.28M | 102.83M | 83.31M | 84.82M | 85.36M |
| Total Receivables | 101.94M | 112.48M | 100.82M | 93.43M | 78.97M |
| Inventory | 101.74M | 101.93M | 99.09M | 103.67M | 108.99M |
| Prepaid Expenses | 5.49M | 3.76M | 4.74M | 5.75M | 5.39M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 294.46M | 321.00M | 287.97M | 287.67M | 278.71M |
|
|
|||||
| Total Current Assets | 294.46M | 321.00M | 287.97M | 287.67M | 278.71M |
| Net Property, Plant & Equipment | 22.08M | 21.81M | 15.99M | 15.64M | 15.00M |
| Long-term Investments | 69.34M | 68.45M | 65.63M | 66.22M | 66.59M |
| Goodwill | 69.34M | 68.45M | 65.63M | 66.22M | 66.59M |
| Total Other Intangibles | 242.70M | 254.27M | 276.79M | 270.96M | 281.61M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 57.60M | 58.25M | 58.76M | 60.69M | 61.96M |
| Total Assets | 735.32M | 780.40M | 763.10M | 752.81M | 761.03M |
|
|
|||||
| Total Accounts Payable | 95.45M | 105.81M | 88.15M | 81.02M | 76.94M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 135.70K | -- | 2.11M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.88M | 15.52M | 14.54M | 15.46M | 14.18M |
| Total Finance Division Other Current Liabilities | 19.80M | 16.89M | 17.70M | 13.13M | 19.65M |
| Total Other Current Liabilities | 19.80M | 16.89M | 17.70M | 13.13M | 19.65M |
| Total Current Liabilities | 129.13M | 138.22M | 120.53M | 109.61M | 112.88M |
|
|
|||||
| Total Current Liabilities | 129.13M | 138.22M | 120.53M | 109.61M | 112.88M |
| Long-Term Debt | 4.81M | 29.25M | 37.32M | 56.53M | 57.81M |
| Short-term Debt | -- | -- | 135.70K | -- | 2.11M |
| Capital Leases | 5.44M | 5.34M | 4.83M | 4.28M | 2.70M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 33.92M | 42.17M | 40.83M | 31.88M | 28.16M |
| Total Liabilities | 173.30M | 214.98M | 203.50M | 202.30M | 201.55M |
|
|
|||||
| Common Stock & APIC | 393.06M | 399.45M | 410.31M | 403.70M | 410.99M |
| Retained Earnings | 110.63M | 115.51M | 108.63M | 100.81M | 105.74M |
| Treasury Stock & Other | 58.33M | 50.46M | 40.65M | 45.99M | 42.76M |
| Total Common Equity | 562.02M | 565.42M | 559.60M | 550.50M | 559.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 562.02M | 565.42M | 559.60M | 550.50M | 559.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 562.02M | 565.42M | 559.60M | 550.50M | 559.48M |
|
|
|||||